Pharmaceutical Group: Roche Trimmes Research for Efficiency and Targets 20 New Drugs

Handelsblatt

Lean Right

Factuality

Ownership

By 2030, Roche intends to launch up to 20 new active substances – with a peak sales potential of some more than three billion Swiss francs per active substance.

iatronet.gr

Factuality

Ownership

By the end of 2026, around 2 billion Swiss francs of the savings will be directed to projects with higher returns.

Moneycab

Factuality

Ownership

Roche has set itself ambitious targets for the coming years: by 2030, the pharmaceutical group intends to produce a total of 20 new, particularly effective medicines, while at the same time becoming the world leader in the productivity of its research.